Pluristem

PSTI NASDAQ
0.5775
+0.0135
+2.39%
已收盘, 16:00 06/24 EDT
开盘
0.5616
昨收
0.5640
最高
0.5800
最低
0.5600
成交量
15.54万
成交均量(3M)
62.51万
52周最高
1.380
52周最低
0.5000
换手率
0.10%
市值
8,614.32万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Pluristem PSTI股票价格,Pluristem股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products include PLX-PAD and PLX R18. The Company's PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company's PLX products are administered using a standard needle and syringe. The Company's PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women's health diseases.
展开 >

最近浏览

名称
价格
涨跌幅